LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

Home・Aktien・Pulmatrix Inc

Pulmatrix Inc

Geschlossen

4.51 0.89

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.46

Max

4.63

Schlüsselkennzahlen
By Trading Economics
Einkommen	672K -877K
EPS	-0.24
Gewinnspanne	-60,266.667
Angestellte	2
EBITDA	671K -877K

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-548K 17M
Vorheriger Eröffnungskurs	3.62
Vorheriger Schlusskurs	4.51

Pulmatrix Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

21. Nov. 2025, 22:42 UTC

Market Talk

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

21. Nov. 2025, 21:50 UTC

Market Talk

Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

21. Nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

21. Nov. 2025, 21:47 UTC

Market Talk

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

21. Nov. 2025, 21:43 UTC

Market Talk

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

21. Nov. 2025, 20:18 UTC

Market Talk

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

21. Nov. 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

21. Nov. 2025, 19:48 UTC

Market Talk

Precious Metals Fall for the Week -- Market Talk

21. Nov. 2025, 19:44 UTC

Ergebnisse

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

21. Nov. 2025, 19:37 UTC

Market Talk

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

21. Nov. 2025, 19:27 UTC

Market Talk

Ergebnisse

Global Equities Roundup: Market Talk

21. Nov. 2025, 19:27 UTC

Market Talk

Ergebnisse

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

21. Nov. 2025, 19:20 UTC

Market Talk

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

21. Nov. 2025, 18:44 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

21. Nov. 2025, 18:37 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

21. Nov. 2025, 18:34 UTC

Market Talk

Ergebnisse

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

21. Nov. 2025, 18:28 UTC

Ergebnisse

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21. Nov. 2025, 18:03 UTC

Market Talk

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

21. Nov. 2025, 17:24 UTC

Market Talk

Global Equities Roundup: Market Talk

21. Nov. 2025, 17:24 UTC

Market Talk

Intuit Seen on Path to Increase Growth -- Market Talk

21. Nov. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

21. Nov. 2025, 17:05 UTC

Market Talk

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

21. Nov. 2025, 16:56 UTC

Market Talk

Gold Recovers as Investors Boost Rate-Cut Bets -- Market Talk

21. Nov. 2025, 16:47 UTC

Market Talk

European Gas-Price Forecast to Decline Further on Expanding LNG Supply -- Market Talk

21. Nov. 2025, 16:35 UTC

Akquisitionen, Fusionen, Übernahmen

What Stocks Al Gore's Investment Firm Bought and Sold This Quarter -- Barrons.com

21. Nov. 2025, 16:09 UTC

Ergebnisse

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21. Nov. 2025, 15:59 UTC

Market Talk

Canadian Consumers Tapping the Brakes, Still See Resilient -- Market Talk

21. Nov. 2025, 15:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21. Nov. 2025, 15:23 UTC

Market Talk

Bank of Canada Not Expected to Be Swayed by Canadian Retail Trade Data -- Market Talk

21. Nov. 2025, 15:17 UTC

Market Talk

Canadian Consumer Spending Softening, But Could Be Worse -- Market Talk

Peer-Vergleich

Kursveränderung

Pulmatrix Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Pulmatrix Inc – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.